World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024

World Top 100 Biopharmaceutical Companies List by Market Cap in January 2024, World Biggest 100 Biopharmaceutical Companies by Market Cap, World Largest 100 Biopharmaceutical Companies in the World by market cap as pf Jan-05-2024.

World Top Biopharmaceutical Companies 2024
World Largest Biopharmaceutical Companies by Market Cap in 2024, World Top Biopharmaceutical Companies by Market Cap in 2024.

  1. Oric Pharmaceuticals Inc.

    World Rank (Jan-05-2024)
    12,752
    Market Cap (Jan-05-2024)
    0.489 Billion USD
    World Rank (Jul-30-2023)
    14,604
    Market Cap (Jul-30-2023)
    0.372 Billion USD
    World Rank (Dec-25-2022)
    17,297
    Market Cap (Dec-25-2022)
    0.229 Billion USD
    World Rank (Jan-07-2022)
    12,703
    Market Cap (Jan-07-2022)
    0.56 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -78 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    ORIC Pharmaceuticals is a Clinical Stage Biopharmaceutical company focused on discovering and developing innovative therapies that benefit patients with cancer. The company annual revenue is 1.07 billion USD and 60 employees as on 2019. The headquarters is in USA.
    Company Website
    ORIC PHARMACEUTICALS, INC.

  2. Nurix Therapeutics Inc.

    World Rank (Jan-05-2024)
    12,883
    Market Cap (Jan-05-2024)
    0.478 Billion USD
    World Rank (Jul-30-2023)
    13,148
    Market Cap (Jul-30-2023)
    0.469 Billion USD
    World Rank (Dec-25-2022)
    12,559
    Market Cap (Dec-25-2022)
    0.489 Billion USD
    World Rank (Jan-07-2022)
    8,355
    Market Cap (Jan-07-2022)
    1.23 Billion USD
    Annual Revenue in USD
    29 Million USD
    Annual Net Income in USD
    -117 Million USD
    Annual Results for Period Ending
    Nov-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Nurix Therapeutics is a  Biopharmaceutical company discovers drugs that harness the bodies natural process to control protein levels and drugs control ubiquitin E3 ligases, the key enzymes responsible for protein breakdown in human cells as a unique therapeutic approach to treat a broad range of diseases. The company annual revenue is 17.8 million USD and 103 employees as on 2019. The headquarters is in USA.
    Company Website
    NURIX THERAPEUTICS, INC.

  3. Fulcrum Therapeutics

    World Rank (Jan-05-2024)
    13,136
    Market Cap (Jan-05-2024)
    0.458 Billion USD
    World Rank (Jul-30-2023)
    17,105
    Market Cap (Jul-30-2023)
    0.238 Billion USD
    World Rank (Dec-25-2022)
    15,206
    Market Cap (Dec-25-2022)
    0.325 Billion USD
    World Rank (Jan-07-2022)
    12,092
    Market Cap (Jan-07-2022)
    0.62 Billion USD
    Annual Revenue in USD
    19 Million USD
    Annual Net Income in USD
    -80 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    Fulcrum Therapeutics is a Clinical Stage Biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need with an initial focus on rare diseases. The company annual revenue is 8.82 million USD and 432 employees as on 2020. The headquarters is in USA.
    Company Website
    FULCRUM THERAPEUTICS

  4. LianBio American Depositary Shares

    World Rank (Jan-05-2024)
    13,238
    Market Cap (Jan-05-2024)
    0.451 Billion USD
    World Rank (Jul-30-2023)
    17,654
    Market Cap (Jul-30-2023)
    0.216 Billion USD
    World Rank (Dec-25-2022)
    18,679
    Market Cap (Dec-25-2022)
    0.177 Billion USD
    World Rank (Jan-07-2022)
    13,160
    Market Cap (Jan-07-2022)
    0.53 Billion USD
    Annual Revenue in USD
    0 Million USD
    Annual Net Income in USD
    -196 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    LianBio is a biopharmaceutical company that treat the specific cause of diseases like cardiovascular, oncology and respiratory. The company total assets are 279.2 million USD as on 2020. The headquarters is in USA.

    Company Website
    LIANBIO

  5. Third Harmonic Bio Inc.

    World Rank (Jan-05-2024)
    13,278
    Market Cap (Jan-05-2024)
    0.448 Billion USD
    World Rank (Jul-30-2023)
    16,457
    Market Cap (Jul-30-2023)
    0.270 Billion USD
    World Rank (Dec-25-2022)
    18,874
    Market Cap (Dec-25-2022)
    0.171 Billion USD
    Headquarters Country
    USA
    Company Website
    THIRD HARMONIC BIO, INC.

  6. Idorsia Ltd

    World Rank (Jan-05-2024)
    13,426
    Market Cap (Jan-05-2024)
    0.438 Billion USD
    World Rank (Jul-30-2023)
    7,285
    Market Cap (Jul-30-2023)
    1.359 Billion USD
    World Rank (Dec-25-2022)
    4,517
    Market Cap (Dec-25-2022)
    2.630 Billion USD
    World Rank (Jan-07-2022)
    4,316
    Market Cap (Jan-07-2022)
    3.53 Billion USD
    Annual Revenue in USD
    37 Million USD
    Annual Net Income in USD
    -678 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Switzerland
    Yahoo @ Switzerland
    Company Profile
    Idorsia Ltd is the leading Biopharmaceutical company specialized in the discovery, development and commercialization of innovative small molecules with the aim of transforming the horizon of therapeutic options. The headquarters is in Switzerland.
    Facts About Company
    The company annual revenue was 97 million CHF and annual net loss was -827 million CHF for year ending Dec-2022.
    Company Website
    IDORSIA LTD

  7. Intercept Pharmaceuticals

    World Rank (Jan-05-2024)
    13,459
    World Rank (Jul-30-2023)
    13,459
    Market Cap (Jul-30-2023)
    0.447 Billion USD
    World Rank (Dec-25-2022)
    12,555
    Market Cap (Dec-25-2022)
    0.490 Billion USD
    World Rank (Jan-07-2022)
    14,284
    Market Cap (Jan-07-2022)
    0.44 Billion USD
    Annual Revenue in USD
    313 Million USD
    Annual Net Income in USD
    -275 Million USD
    Annual Results for Period Ending
    Dec-2020 ending year
    Headquarters Country
    USA
    Company Profile

    Intercept Pharmaceuticals is a biotechnology sector company. The headquarters is in USA.

    Company Website
    INTERCEPT PHARMACEUTICALS INC

  8. Albireo Pharma

    World Rank (Jan-05-2024)
    13,865
    World Rank (Jul-30-2023)
    13,865
    Market Cap (Jul-30-2023)
    0.921 Billion USD
    World Rank (Dec-25-2022)
    13,865
    Market Cap (Dec-25-2022)
    0.401 Billion USD
    World Rank (Jan-07-2022)
    13,446
    Market Cap (Jan-07-2022)
    0.50 Billion USD
    Annual Revenue in USD
    40 Million USD
    Annual Net Income in USD
    -34 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Company Profile

    Albireo is a Clinical Stage Biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases and other adult liver diseases and disorders. The company annual revenue is 8.3 million USD and 55 employees as on 2020. The headquarters is in USA.

    Company Website
    ALBIREO PHARMA

  9. iTeos Therapeutics Inc.

    World Rank (Jan-05-2024)
    13,965
    Market Cap (Jan-05-2024)
    0.400 Billion USD
    World Rank (Jul-30-2023)
    12,768
    Market Cap (Jul-30-2023)
    0.499 Billion USD
    World Rank (Dec-25-2022)
    10,597
    Market Cap (Dec-25-2022)
    0.669 Billion USD
    World Rank (Jan-07-2022)
    7,393
    Market Cap (Jan-07-2022)
    1.52 Billion USD
    Annual Revenue in USD
    344 Million USD
    Annual Net Income in USD
    214 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    USA
    Yahoo @ Nasdaq
    Company Profile
    iTeos Therapeutics is a Clinical Stage Biopharmaceutical Company pioneering the discovery and development of a new generation of highly differentiated immuno oncology therapeutics for patients. It innovative pipeline includes two clinical stage programs targeting novel, validated immuno oncology pathways designed to build on prior learnings in the field to have differentiated pharmacological and clinical profiles. The headquarters is in USA.
    Company Website
    ITEOS THERAPEUTICS, INC.

  10. Samyang Holdings Corporation

    World Rank (Jan-05-2024)
    14,052
    Market Cap (Jan-05-2024)
    0.396 Billion USD
    World Rank (Jul-30-2023)
    13,785
    Market Cap (Jul-30-2023)
    0.425 Billion USD
    World Rank (Dec-25-2022)
    13,606
    Market Cap (Dec-25-2022)
    0.417 Billion USD
    World Rank (Jan-07-2022)
    12,198
    Market Cap (Jan-07-2022)
    0.61 Billion USD
    Annual Revenue in USD
    2,324 Million USD
    Annual Net Income in USD
    178 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    South Korea
    Yahoo @ SouthKorea
    Company Website
    SAMYANG HOLDINGS CORPORATION

Share